The clotting system is a complex biological pathway involving multiple proteins that work together to stop bleeding. Factor VII is part of the extrinsic pathway, one of the first steps activated when a blood vessel is damaged. It helps trigger a chain reaction that ultimately leads to fibrin formation, which stabilizes blood clots. In dogs affected by Factor VII Deficiency, this pathway is disrupted, meaning clots form more slowly or may be unstable.
Clinical signs of FVIID can vary widely depending on the severity of the deficiency. Many affected dogs show mild or no obvious symptoms in everyday life, while others may experience noticeable bleeding tendencies. Common signs include prolonged bleeding after surgery or injury, nosebleeds (epistaxis), bleeding gums, easy bruising, or excessive bleeding following routine procedures such as vaccinations or dental work. In severe cases, internal bleeding may occur, although this is less common.
Because symptoms can be subtle, Factor VII Deficiency is often only discovered during pre-surgical screening or genetic testing. Affected dogs may appear healthy until they undergo a procedure that challenges the clotting system, at which point abnormal bleeding becomes evident.
The FVIID DNA Health Test is designed to detect the specific genetic mutation responsible for Factor VII Deficiency. Testing is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to determine the dog’s genetic status. Since DNA does not change over time, testing can be done at any age, including in puppies before any clinical signs appear.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the Factor VII mutation and is not expected to develop or pass on the condition.
- Carrier: The dog carries one copy of the mutation but typically does not show clinical signs. However, it can pass the mutation to offspring.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Factor VII Deficiency and experiencing abnormal bleeding.
Genetic testing for FVIID provides valuable information for breeders, veterinarians, and dog owners. Breeders can use results to make informed mating decisions that reduce or eliminate the mutation from breeding lines while maintaining genetic diversity. Avoiding carrier-to-carrier breeding significantly reduces the risk of producing affected puppies.
For dog owners, understanding a dog’s genetic status allows for proactive health management. Dogs identified as affected or at risk should be carefully monitored during surgical procedures, injury treatment, or dental care. Veterinarians may take additional precautions such as pre-surgical screening or availability of blood products to manage bleeding risks effectively.
The Factor VII Deficiency (FVIID) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine blood health, and helps reduce the impact of this inherited clotting disorder in future generations.
